- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- hetero-6-6-6-6-mer
- Ligands
- 6 x SPH: SPHINGOSINE(Non-covalent)
- 36 x NA: SODIUM ION(Non-functional Binders)
NA.2: 4 residues within 4Å:- Chain A: T.28, G.29, N.31, N.71
Ligand excluded by PLIPNA.3: 4 residues within 4Å:- Chain A: S.56, T.58
- Chain C: E.116, Q.221
Ligand excluded by PLIPNA.4: 7 residues within 4Å:- Chain A: V.44, P.45, L.47, Q.48
- Chain D: E.63, A.65, P.67
Ligand excluded by PLIPNA.5: 3 residues within 4Å:- Chain A: E.164, S.165, S.168
Ligand excluded by PLIPNA.6: 5 residues within 4Å:- Chain A: S.15, S.17
- Chain B: S.40, Y.41, R.103
Ligand excluded by PLIPNA.7: 4 residues within 4Å:- Chain A: Q.189
- Chain C: V.20, S.21
- Chain G: P.8
Ligand excluded by PLIPNA.10: 4 residues within 4Å:- Chain E: T.28, G.29, N.31, N.71
Ligand excluded by PLIPNA.11: 4 residues within 4Å:- Chain E: S.56, T.58
- Chain G: E.116, Q.221
Ligand excluded by PLIPNA.12: 7 residues within 4Å:- Chain E: V.44, P.45, L.47, Q.48
- Chain H: E.63, A.65, P.67
Ligand excluded by PLIPNA.13: 3 residues within 4Å:- Chain E: E.164, S.165, S.168
Ligand excluded by PLIPNA.14: 5 residues within 4Å:- Chain E: S.15, S.17
- Chain F: S.40, Y.41, R.103
Ligand excluded by PLIPNA.15: 3 residues within 4Å:- Chain E: Q.189
- Chain G: V.20, S.21
Ligand excluded by PLIPNA.18: 4 residues within 4Å:- Chain I: T.28, G.29, N.31, N.71
Ligand excluded by PLIPNA.19: 4 residues within 4Å:- Chain I: S.56, T.58
- Chain K: E.116, Q.221
Ligand excluded by PLIPNA.20: 7 residues within 4Å:- Chain I: V.44, P.45, L.47, Q.48
- Chain L: E.63, A.65, P.67
Ligand excluded by PLIPNA.21: 3 residues within 4Å:- Chain I: E.164, S.165, S.168
Ligand excluded by PLIPNA.22: 5 residues within 4Å:- Chain I: S.15, S.17
- Chain J: S.40, Y.41, R.103
Ligand excluded by PLIPNA.23: 3 residues within 4Å:- Chain I: Q.189
- Chain K: V.20, S.21
Ligand excluded by PLIPNA.26: 4 residues within 4Å:- Chain M: T.28, G.29, N.31, N.71
Ligand excluded by PLIPNA.27: 4 residues within 4Å:- Chain M: S.56, T.58
- Chain O: E.116, Q.221
Ligand excluded by PLIPNA.28: 7 residues within 4Å:- Chain M: V.44, P.45, L.47, Q.48
- Chain P: E.63, A.65, P.67
Ligand excluded by PLIPNA.29: 3 residues within 4Å:- Chain M: E.164, S.165, S.168
Ligand excluded by PLIPNA.30: 5 residues within 4Å:- Chain M: S.15, S.17
- Chain N: S.40, Y.41, R.103
Ligand excluded by PLIPNA.31: 4 residues within 4Å:- Chain K: P.8
- Chain M: Q.189
- Chain O: V.20, S.21
Ligand excluded by PLIPNA.34: 4 residues within 4Å:- Chain Q: T.28, G.29, N.31, N.71
Ligand excluded by PLIPNA.35: 4 residues within 4Å:- Chain Q: S.56, T.58
- Chain S: E.116, Q.221
Ligand excluded by PLIPNA.36: 7 residues within 4Å:- Chain Q: V.44, P.45, L.47, Q.48
- Chain T: E.63, A.65, P.67
Ligand excluded by PLIPNA.37: 3 residues within 4Å:- Chain Q: E.164, S.165, S.168
Ligand excluded by PLIPNA.38: 5 residues within 4Å:- Chain Q: S.15, S.17
- Chain R: S.40, Y.41, R.103
Ligand excluded by PLIPNA.39: 4 residues within 4Å:- Chain Q: Q.189
- Chain S: V.20, S.21
- Chain W: P.8
Ligand excluded by PLIPNA.42: 4 residues within 4Å:- Chain U: T.28, G.29, N.31, N.71
Ligand excluded by PLIPNA.43: 4 residues within 4Å:- Chain U: S.56, T.58
- Chain W: E.116, Q.221
Ligand excluded by PLIPNA.44: 7 residues within 4Å:- Chain U: V.44, P.45, L.47, Q.48
- Chain X: E.63, A.65, P.67
Ligand excluded by PLIPNA.45: 3 residues within 4Å:- Chain U: E.164, S.165, S.168
Ligand excluded by PLIPNA.46: 5 residues within 4Å:- Chain U: S.15, S.17
- Chain V: S.40, Y.41, R.103
Ligand excluded by PLIPNA.47: 3 residues within 4Å:- Chain U: Q.189
- Chain W: V.20, S.21
Ligand excluded by PLIP- 6 x CL: CHLORIDE ION(Non-functional Binders)
CL.8: 6 residues within 4Å:- Chain C: D.89, P.90, G.91, W.111, H.180, A.181
Ligand excluded by PLIPCL.16: 6 residues within 4Å:- Chain G: D.89, P.90, G.91, W.111, H.180, A.181
Ligand excluded by PLIPCL.24: 6 residues within 4Å:- Chain K: D.89, P.90, G.91, W.111, H.180, A.181
Ligand excluded by PLIPCL.32: 6 residues within 4Å:- Chain O: D.89, P.90, G.91, W.111, H.180, A.181
Ligand excluded by PLIPCL.40: 6 residues within 4Å:- Chain S: D.89, P.90, G.91, W.111, H.180, A.181
Ligand excluded by PLIPCL.48: 6 residues within 4Å:- Chain W: D.89, P.90, G.91, W.111, H.180, A.181
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Plevka, P. et al., Structure of Human Enterovirus 71 in Complex with a Capsid-Binding Inhibitor. Proc.Natl.Acad.Sci.USA (2013)
- Release Date
- 2013-03-27
- Peptides
- VP1: AEIMQU
VP2: BFJNRV
VP3: CGKOSW
VP4: DHLPTX - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
AI
AM
AQ
AU
AB
BF
BJ
BN
BR
BV
BC
CG
CK
CO
CS
CW
CD
DH
DL
DP
DT
DX
D
SMTL ID : 3zfe.3 (3 other biounits)
Human enterovirus 71 in complex with capsid binding inhibitor WIN51711
VP1
Toggle Identical (AEIMQU)VP2
Toggle Identical (BFJNRV)VP3
Toggle Identical (CGKOSW)VP4
Toggle Identical (DHLPTX)Related Entries With Identical Sequence
3zfe.1 | 3zfe.2 | 3zfe.4 | 3zff.1 | 3zff.2 | 3zff.3 | 3zff.4 | 3zfg.1 | 3zfg.2 | 3zfg.3 | 3zfg.4 | 4aed.1 | 4aed.2 | 4aed.3 | 4aed.4 | 4c0u.1 | 4c0u.2 | 4c0u.3 | 4c0u.4 | 4c0y.1 | 4c0y.2 | 4c0y.3 | 4c0y.4 | 4c10.1 | 4c10.2 | 4c10.3 | 4c10.4 | 4cdq.1 | 4cdq.2 | 4cdq.3 more...less...4cdq.4 | 4cdu.1 | 4cdu.2 | 4cdu.3 | 4cdu.4 | 4cdw.1 | 4cdw.2 | 4cdw.3 | 4cdw.4 | 4cdx.1 | 4cdx.2 | 4cdx.3 | 4cdx.4 | 4cew.1 | 4cew.2 | 4cew.3 | 4cew.4 | 4cey.1 | 4cey.2 | 4cey.3 | 4cey.4 | 4n53.1 | 4n53.2 | 4n53.3 | 4n53.4 | 6lqd.1 | 6lqd.2 | 6lqd.3 | 6lqd.4 | 6uh1.1 | 6uh1.2 | 6uh1.3 | 6uh1.4 | 6uh6.1 | 6uh6.2 | 6uh6.3 | 6uh6.4 | 6uh7.1 | 6uh7.2 | 6uh7.3 | 6uh7.4 | 8e2x.1 | 8e2x.2 | 8e2x.3 | 8e2x.4 | 8e38.1 | 8e38.2 | 8e38.3 | 8e38.4 | 8e39.1 | 8e39.2 | 8e39.3 | 8e39.4 | 8e3a.1 | 8e3a.2 | 8e3a.3 | 8e3a.4 | 8x95.1 | 8x95.2 | 8x95.3 | 8x95.4 | 8ytj.1 | 8ytj.2 | 8ytj.3 | 8ytj.4